Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-07

Clinical Trial Update: Zidovudine Levels in HIV Infected Patients Being Treated for HCV [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on zidovudine concentration levels in HIV-infected patients treated for hepatitis C in Phase 1 and Phase 2 studies. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED